SCHEMBL1017280

SCHEMBL1017280

CC1CCCC2CN(C(=O)CN3CCc4cc(Br)ccc4C3)CCN12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.41
BIRC2 Q13490 1/20 0.41
CARM1 Q86X55 2/20 0.40
ALDH1A1 P00352 4/20 0.39
ACACB O00763 1/20 0.39
PKM P14618 2/20 0.37
GAA P10253 2/20 0.37
HSD17B10 Q99714 1/20 0.37
PRMT5 O14744 3/20 0.36
WDR77 Q9BQA1 1/20 0.35
ABHD6 Q9BV23 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707063 1.00 XIAP (0.41) XIAPBIRC2CARM1ALDH1A1ACACB
SCHEMBL1604154 0.89 CARM1 (0.41) XIAPBIRC2CARM1ALDH1A1ACACB
SCHEMBL12707109 0.89 CARM1 (0.41) XIAPBIRC2CARM1ALDH1A1ACACB
SCHEMBL1020289 0.88 KDM2B (0.39) ALDH1A1PKMGAAHSD17B10PRMT5
SCHEMBL1013903 0.84 HRH3 (0.38) ALDH1A1ACACBPKMGAAHSD17B10
SCHEMBL12707069 0.84 HRH3 (0.38) ALDH1A1ACACBPKMGAAHSD17B10
SCHEMBL1018279 0.83 TP53 (0.48) CARM1ALDH1A1ACACBPKMGAA
SCHEMBL1017287 0.83 FAAH (0.44) CARM1ALDH1A1ACACBPKMGAA
SCHEMBL12707078 0.82 PRMT5 (0.40) ALDH1A1PKMGAAHSD17B10PRMT5
SCHEMBL1014842 0.82 PRMT5 (0.40) ALDH1A1PKMGAAHSD17B10PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 XIAP 4475/4885BIRC2 4377/4885CARM1 1039/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 XIAP 4475/4885BIRC2 4377/4885CARM1 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.